Research graph
References from Eosinophilic gastritis: burden of disease, diagnostic challenges and unmet needs. Local targets link to admitted publications; unresolved targets remain external evidence.
International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature
10.1016/j.cgh.2022.02.017 · 2022 · External reference
Common and disparate clinical presentations and mechanisms in different eosinophilic gastrointestinal diseases
10.1016/j.jaci.2024.03.013 · 2024 · External reference
10.1016/j.jaci.2003.10.047
10.1016/j.jaci.2003.10.047 · External reference
Prevalence of Eosinophilic Gastritis, Gastroenteritis, and Colitis: Estimates From a National Administrative Database
10.1097/mpg.0000000000000865 · 2016 · External reference
Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter Consortium
10.14309/ajg.0000000000000228 · 2019 · External reference
Epidemiology of Nonesophageal Eosinophilic Gastrointestinal Diseases in Symptomatic Patients: A Systematic Review and Meta-Analysis
10.1016/j.jaip.2020.01.060 · 2020 · External reference
Prevalence and Costs of Non-esophageal Eosinophilic Gastrointestinal Diseases in the United States
10.1007/s10620-026-09835-4 · 2026 · External reference
Eosinophilic Gastroenteritis: Clinical Manifestation, Natural Course, and Evaluation of Treatment with Corticosteroids and Vedolizumab
10.1007/s10620-019-05617-3 · 2019 · External reference
Natural history of eosinophilic gastroenteritis
10.1016/j.cgh.2011.07.017 · 2011 · External reference
Eosinophilic Gastrointestinal Diseases Beyond Eosinophilic Esophagitis
10.14309/ajg.0000000000001658 · 2022 · External reference
Impact on Health-Related Quality of Life in Adults with Eosinophilic Gastritis and Gastroenteritis: A Qualitative Assessment
10.1007/s10620-018-4978-7 · 2018 · External reference
Joint ESPGHAN/NASPGHAN Guidelines on Childhood Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis
10.1097/mpg.0000000000003877 · 2024 · External reference
Letter: budesonide for functional dyspepsia with duodenal eosinophilia—randomised, double‐blind, placebo‐controlled parallel‐group trial
10.1111/apt.16396 · 2021 · External reference
10.1016/j.cgh.2017.05.050
10.1016/j.cgh.2017.05.050 · External reference
Overestimation of the diagnosis of eosinophilic colitis with reliance on billing codes
2019 · External reference
10.1053/j.gastro.2022.12.015
10.1053/j.gastro.2022.12.015 · External reference
Epidemiology and risk factors of non-esophageal eosinophilic gastrointestinal diseases in Japan: A population-based study
10.1016/j.alit.2024.10.007 · 2025 · External reference
Challenging assumptions about the demographics of eosinophilic gastrointestinal diseases: A systematic review
10.1016/j.jacig.2024.100260 · 2024 · External reference
Clinical Characteristics and Treatment Outcomes of Patients with Eosinophilic Esophagitis and Eosinophilic Gastroenteritis
10.1159/000511588 · 2021 · External reference
Diagnostic Delay in Patients with Eosinophilic Gastritis and/or Duodenitis: A Population-Based Study
10.1016/j.jaip.2020.12.054 · 2021 · External reference
Gastroenterology Practice Patterns Contribute to Missed Diagnoses of Eosinophilic Gastritis and Duodenitis
10.1016/j.gastha.2022.11.010 · 2023 · External reference
Epidemiology, Natural History, and Treatment of Eosinophilic Gastrointestinal Diseases
10.1053/j.gastro.2025.09.030 · 2026 · External reference
Eosinophilic gastroenteritis: diagnosis and clinical perspectives
10.2147/ceg.s173130 · 2019 · External reference
10.1016/j.jaci.2019.11.013
10.1016/j.jaci.2019.11.013 · External reference
10.1007/s10875-017-0429-z
10.1007/s10875-017-0429-z · External reference
10.1038/86365
10.1038/86365 · External reference
Prospective study of an amino acid-based elemental diet in an eosinophilic gastritis and gastroenteritis nutrition trial
10.1016/j.jaci.2023.05.024 · 2023 · External reference
A Systematic Review and Meta-Analysis on the Induction of Confirmed Eosinophilic Esophagitis as a Side Effect of Allergen Immunotherapy: An EAACI Task Force Report
10.1111/all.70183 · 2026 · External reference
A CASE OF EOSINOPHILIC GASTROENTERITIS FOUND BY PICA DURING ORAL IMMUNOTHERAPY
2020 · External reference
Eosinophilic gastroenteritis developed after remission of cow’s milk allergy
10.1111/ped.14078 · 2020 · External reference
Primary eosinophilic gastrointestinal disorders in children who have received food oral immunotherapy
10.1016/j.aller.2016.05.002 · 2016 · External reference
Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome
10.1016/j.jaci.2014.07.026 · 2014 · External reference
Gene Expression Patterns in Distinct Endoscopic Findings for Eosinophilic Gastritis in Children
10.1016/j.jaip.2017.03.030 · 2017 · External reference
Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study
10.1016/j.jaci.2019.11.007 · 2020 · External reference
Local type 2 immunity in eosinophilic gastritis
10.1016/j.jaci.2023.01.021 · 2023 · External reference
Peripheral eosinophilia and hypoalbuminemia are associated with a higher biopsy diagnostic yield for eosinophilic gastroenteritis
10.1016/j.clinre.2021.101746 · 2021 · External reference
Mast Cell and Eosinophil Counts in Gastric and Duodenal Biopsy Specimens From Patients With and Without Eosinophilic Gastroenteritis
10.1016/j.cgh.2020.08.013 · 2021 · External reference
10.1097/00005792-197007000-00003
10.1097/00005792-197007000-00003 · External reference
10.1136/gut.31.1.54
10.1136/gut.31.1.54 · External reference
Dietary Management of Non-EoE Eosinophilic Gastrointestinal Diseases
10.1016/j.iac.2024.01.009 · 2024 · External reference
Clinical features and treatment outcomes of eosinophilic gastroenteritis: an analysis of 28 cases
2019 · External reference
10.1016/j.cgh.2010.04.022
10.1016/j.cgh.2010.04.022 · External reference
Eosinophilic gastroenteritis: Clinical profiles and treatment outcomes, a retrospective study of 18 adult patients in a Singapore Tertiary Hospital
2015 · External reference
Eosinophilic Gastrointestinal Diseases Beyond the Esophagus: An Evolving Field and Nomenclature
2022 · External reference
Non-esophageal eosinophilic gastrointestinal diseases: a narrative review
10.51821/86.3.11869 · 2023 · External reference
10.1097/01.mpg.0000221903.61157.4e
10.1097/01.mpg.0000221903.61157.4e · External reference
Transmural eosinophilic gastritis with gastric outlet obstruction: case report and review of the literature
10.1308/147870810x12659688851915 · 2010 · External reference
Eosinophilic gastroenteritis: Clinical experience with 15 patients
10.3748/wjg.v9.i12.2813 · 2003 · External reference
Determination of Optimal Eosinophil Thresholds for Diagnosis of Eosinophilic Gastritis and Duodenitis: A Pooled Analysis of 4 Prospective Studies
10.14309/ctg.0000000000000656 · 2024 · External reference
Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal Disorders
10.1007/s10620-019-05961-4 · 2020 · External reference
Prospective Endoscopic Activity Assessment for Eosinophilic Gastritis in a Multisite Cohort
10.14309/ajg.0000000000001625 · 2022 · External reference
Determination of Biopsy Yield That Optimally Detects Eosinophilic Gastritis and/or Duodenitis in a Randomized Trial of Lirentelimab
10.1016/j.cgh.2021.05.053 · 2022 · External reference
Eosinophilic Gastritis/Gastroenteritis
10.1007/s11894-021-00809-2 · 2021 · External reference
Substantial Variability in Biopsy Practice Patterns Among Gastroenterologists for Suspected Eosinophilic Gastrointestinal Disorders
10.1016/j.cgh.2016.04.025 · 2016 · External reference
Collagenous Gastritis Masquerading as Eosinophilic Gastritis
10.14309/crj.0000000000000527 · 2021 · External reference
10.1097/pas.0000000000000481
10.1097/pas.0000000000000481 · External reference
Non-oesophageal eosinophilic gastrointestinal diseases are undersuspected clinically and underdiagnosed pathologically
10.1111/apt.16971 · 2022 · External reference
Do General Pathologists Assess Gastric and Duodenal Eosinophilia?
10.5858/arpa.2022-0204-oa · 2023 · External reference
Clinical characteristics, treatment outcomes, and resource utilization in children and adults with eosinophilic gastroenteritis
10.1016/j.dld.2014.11.009 · 2015 · External reference
Initial Validation of the Eosinophilic Gastritis and Gastroenteritis Quality of Life Scale
10.1016/j.gastha.2025.100627 · 2025 · External reference
Individuals affected by eosinophilic gastrointestinal disorders have complex unmet needs and frequently experience unique barriers to care
10.1016/j.clinre.2018.03.003 · 2018 · External reference
High Patient Disease Burden in a Cross-sectional, Multicenter Contact Registry Study of Eosinophilic Gastrointestinal Diseases
10.1097/mpg.0000000000002817 · 2020 · External reference
10.1016/j.jpeds.2009.11.008
10.1016/j.jpeds.2009.11.008 · External reference
Psychiatric Comorbidities Are Highly Prevalent in Nonesophageal Eosinophilic Gastrointestinal Diseases
10.1016/j.cgh.2021.05.044 · 2022 · External reference
Correlation between anxiety and decreased quality of life in patients with non-esophageal eosinophilic gastrointestinal diseases
10.1002/jgh3.13025 · 2024 · External reference
The Economic Burden of Eosinophilic Gastritis and Eosinophilic Enteritis in the United States
10.1007/s12325-022-02202-5 · 2022 · External reference
Biologics in eosinophilic gastrointestinal diseases
10.1016/j.anai.2022.06.015 · 2023 · External reference
Retrospective study of budesonide in children with eosinophilic gastroenteritis
10.1038/s41390-019-0444-2 · 2019 · External reference
Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience
10.1016/j.jaip.2019.01.053 · 2019 · External reference
10.1038/ajg.2014.166
10.1038/ajg.2014.166 · External reference
Efficacy of Dietary Treatment for Inducing Disease Remission in Eosinophilic Gastroenteritis
10.1097/mpg.0000000000000766 · 2015 · External reference
Elemental diet therapy for eosinophilic gastroenteritis and dietary habits
10.1111/ped.14894 · 2022 · External reference
Clinical, histopathological features and efficacy of elimination diet and proton-pump inhibitor therapy in achieving histological remission in Asian children with eosinophilic gastritis
10.1111/jpc.15969 · 2022 · External reference
Tolerability and safety of a new elimination diet for pediatric eosinophilic gastritis and duodenitis
10.1016/j.alit.2022.11.001 · 2023 · External reference
10.1056/nejmoa2012047
10.1056/nejmoa2012047 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome
10.1056/nejmoa1812185 · 2019 · External reference
Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial
10.1016/s2468-1253(23)00145-0 · 2023 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Pilot study of anti-IL-5 in eosinophilic gastroenteritis
10.1016/s0091-6749(03)80986-7 · 2003 · External reference
10.1016/j.jaci.2004.08.027
10.1016/j.jaci.2004.08.027 · External reference
Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report
10.1186/s13223-020-00423-3 · 2020 · External reference
Severe asthma with eosinophilic gastroenteritis effectively managed by mepolizumab and omalizumab
10.1016/j.anai.2018.07.030 · 2018 · External reference
Successful Treatment of Steroid-resistant Eosinophilic Gastrointestinal Disease with Mepolizumab
10.2169/internalmedicine.0801-22 · 2023 · External reference
The Unusual Clinical Presentation of Eosinophilic Gastroenteritis and Its Response to Mepolizumab: Two Case Reports
2024 · External reference
Unresolved reference
External reference
10.17235/reed.2024.10660/2024
10.17235/reed.2024.10660/2024 · External reference
Vedolizumab Treatment May Reduce Steroid Burden and Improve Histology in Patients With Eosinophilic Gastroenteritis
10.1016/j.cgh.2018.03.024 · 2018 · External reference
Combined eosinophilic gastroenteritis and ulcerative colitis successfully treated by vedolizumab: a case report
10.5217/ir.2024.00013 · 2025 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Dupilumab Can Induce Remission of Eosinophilic Gastritis and Duodenitis: A Retrospective Case Series
10.14309/ctg.0000000000000646 · 2024 · External reference
A Case Series on the Use of Dupilumab for Treatment of Refractory Eosinophilic Gastrointestinal Disorders
10.1097/mpg.0000000000003512 · 2022 · External reference
Dupilumab Leads to Clinical Improvements including the Acquisition of Tolerance to Causative Foods in Non-Eosinophilic Esophagitis Eosinophilic Gastrointestinal Disorders
10.3390/biom13010112 · 2023 · External reference
Unresolved reference
External reference
Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial
10.1016/s2468-1253(26)00116-0 · 2026 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1016/j.jaci.2007.06.015
10.1016/j.jaci.2007.06.015 · External reference
10.1186/1476-7961-9-7
10.1186/1476-7961-9-7 · External reference
10.1016/j.jaci.2020.09.039
10.1016/j.jaci.2020.09.039 · External reference
Eosinophilic gastroenteritis as a cause of gastrointestinal tract bleeding and protein-losing enteropathy
10.14744/turkpediatriars.2018.48376 · 2020 · External reference
10.2169/internalmedicine.53.2111
10.2169/internalmedicine.53.2111 · External reference
Proton pump inhibitor treatment decreased duodenal and esophageal eosinophilia in a case of eosinophilic gastroenteritis
10.1016/j.alit.2015.06.002 · 2015 · External reference
Successful use of montelukast in eosinophilic gastroenteritis: a case report and a literature review
10.1186/s12876-021-01854-x · 2021 · External reference
Neuropsychiatric reactions with the use of montelukast
10.1136/bmj-2021-067554 · 2022 · External reference
Intestinal mast cell-derived leukotrienes mediate the anaphylactic response to ingested antigens
10.1126/science.adp0246 · 2025 · External reference
Cysteinyl leukotrienes stimulate gut absorption of food allergens to promote anaphylaxis in mice
10.1126/science.adp0240 · 2025 · External reference
The oesophagus as an immune organ
10.1038/s41575-025-01086-4 · 2025 · External reference
Correlation between anxiety and decreased quality of life in patients with non-esophageal eosinophilic gastrointestinal diseases
10.1002/jgh3.13025 · ExternalCitation · doi-reference
Impact on Health-Related Quality of Life in Adults with Eosinophilic Gastritis and Gastroenteritis: A Qualitative Assessment
10.1007/s10620-018-4978-7 · ExternalCitation · doi-reference
Eosinophilic Gastroenteritis: Clinical Manifestation, Natural Course, and Evaluation of Treatment with Corticosteroids and Vedolizumab
10.1007/s10620-019-05617-3 · ExternalCitation · doi-reference
Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal Disorders
10.1007/s10620-019-05961-4 · ExternalCitation · doi-reference
Prevalence and Costs of Non-esophageal Eosinophilic Gastrointestinal Diseases in the United States
10.1007/s10620-026-09835-4 · ExternalCitation · doi-reference
10.1007/s10875-017-0429-z
10.1007/s10875-017-0429-z · ExternalCitation · doi-reference
Eosinophilic Gastritis/Gastroenteritis
10.1007/s11894-021-00809-2 · ExternalCitation · doi-reference
The Economic Burden of Eosinophilic Gastritis and Eosinophilic Enteritis in the United States
10.1007/s12325-022-02202-5 · ExternalCitation · doi-reference
Proton pump inhibitor treatment decreased duodenal and esophageal eosinophilia in a case of eosinophilic gastroenteritis
10.1016/j.alit.2015.06.002 · ExternalCitation · doi-reference
Tolerability and safety of a new elimination diet for pediatric eosinophilic gastritis and duodenitis
10.1016/j.alit.2022.11.001 · ExternalCitation · doi-reference
Epidemiology and risk factors of non-esophageal eosinophilic gastrointestinal diseases in Japan: A population-based study
10.1016/j.alit.2024.10.007 · ExternalCitation · doi-reference
Primary eosinophilic gastrointestinal disorders in children who have received food oral immunotherapy
10.1016/j.aller.2016.05.002 · ExternalCitation · doi-reference
Severe asthma with eosinophilic gastroenteritis effectively managed by mepolizumab and omalizumab
10.1016/j.anai.2018.07.030 · ExternalCitation · doi-reference
Biologics in eosinophilic gastrointestinal diseases
10.1016/j.anai.2022.06.015 · ExternalCitation · doi-reference
10.1016/j.cgh.2010.04.022
10.1016/j.cgh.2010.04.022 · ExternalCitation · doi-reference
Natural history of eosinophilic gastroenteritis
10.1016/j.cgh.2011.07.017 · ExternalCitation · doi-reference
Substantial Variability in Biopsy Practice Patterns Among Gastroenterologists for Suspected Eosinophilic Gastrointestinal Disorders
10.1016/j.cgh.2016.04.025 · ExternalCitation · doi-reference
10.1016/j.cgh.2017.05.050
10.1016/j.cgh.2017.05.050 · ExternalCitation · doi-reference
Vedolizumab Treatment May Reduce Steroid Burden and Improve Histology in Patients With Eosinophilic Gastroenteritis
10.1016/j.cgh.2018.03.024 · ExternalCitation · doi-reference
Mast Cell and Eosinophil Counts in Gastric and Duodenal Biopsy Specimens From Patients With and Without Eosinophilic Gastroenteritis
10.1016/j.cgh.2020.08.013 · ExternalCitation · doi-reference
Psychiatric Comorbidities Are Highly Prevalent in Nonesophageal Eosinophilic Gastrointestinal Diseases
10.1016/j.cgh.2021.05.044 · ExternalCitation · doi-reference
Determination of Biopsy Yield That Optimally Detects Eosinophilic Gastritis and/or Duodenitis in a Randomized Trial of Lirentelimab
10.1016/j.cgh.2021.05.053 · ExternalCitation · doi-reference
International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature
10.1016/j.cgh.2022.02.017 · ExternalCitation · doi-reference
Individuals affected by eosinophilic gastrointestinal disorders have complex unmet needs and frequently experience unique barriers to care
10.1016/j.clinre.2018.03.003 · ExternalCitation · doi-reference
Peripheral eosinophilia and hypoalbuminemia are associated with a higher biopsy diagnostic yield for eosinophilic gastroenteritis
10.1016/j.clinre.2021.101746 · ExternalCitation · doi-reference
Clinical characteristics, treatment outcomes, and resource utilization in children and adults with eosinophilic gastroenteritis
10.1016/j.dld.2014.11.009 · ExternalCitation · doi-reference
Gastroenterology Practice Patterns Contribute to Missed Diagnoses of Eosinophilic Gastritis and Duodenitis
10.1016/j.gastha.2022.11.010 · ExternalCitation · doi-reference
Initial Validation of the Eosinophilic Gastritis and Gastroenteritis Quality of Life Scale
10.1016/j.gastha.2025.100627 · ExternalCitation · doi-reference
Dietary Management of Non-EoE Eosinophilic Gastrointestinal Diseases
10.1016/j.iac.2024.01.009 · ExternalCitation · doi-reference
10.1016/j.jaci.2003.10.047
10.1016/j.jaci.2003.10.047 · ExternalCitation · doi-reference
10.1016/j.jaci.2004.08.027
10.1016/j.jaci.2004.08.027 · ExternalCitation · doi-reference
10.1016/j.jaci.2007.06.015
10.1016/j.jaci.2007.06.015 · ExternalCitation · doi-reference
Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome
10.1016/j.jaci.2014.07.026 · ExternalCitation · doi-reference
Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study
10.1016/j.jaci.2019.11.007 · ExternalCitation · doi-reference
10.1016/j.jaci.2019.11.013
10.1016/j.jaci.2019.11.013 · ExternalCitation · doi-reference
10.1016/j.jaci.2020.09.039
10.1016/j.jaci.2020.09.039 · ExternalCitation · doi-reference
Local type 2 immunity in eosinophilic gastritis
10.1016/j.jaci.2023.01.021 · ExternalCitation · doi-reference
Prospective study of an amino acid-based elemental diet in an eosinophilic gastritis and gastroenteritis nutrition trial
10.1016/j.jaci.2023.05.024 · ExternalCitation · doi-reference
Common and disparate clinical presentations and mechanisms in different eosinophilic gastrointestinal diseases
10.1016/j.jaci.2024.03.013 · ExternalCitation · doi-reference
Challenging assumptions about the demographics of eosinophilic gastrointestinal diseases: A systematic review
10.1016/j.jacig.2024.100260 · ExternalCitation · doi-reference
Gene Expression Patterns in Distinct Endoscopic Findings for Eosinophilic Gastritis in Children
10.1016/j.jaip.2017.03.030 · ExternalCitation · doi-reference
Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience
10.1016/j.jaip.2019.01.053 · ExternalCitation · doi-reference
Epidemiology of Nonesophageal Eosinophilic Gastrointestinal Diseases in Symptomatic Patients: A Systematic Review and Meta-Analysis
10.1016/j.jaip.2020.01.060 · ExternalCitation · doi-reference
Diagnostic Delay in Patients with Eosinophilic Gastritis and/or Duodenitis: A Population-Based Study
10.1016/j.jaip.2020.12.054 · ExternalCitation · doi-reference
10.1016/j.jpeds.2009.11.008
10.1016/j.jpeds.2009.11.008 · ExternalCitation · doi-reference
Pilot study of anti-IL-5 in eosinophilic gastroenteritis
10.1016/s0091-6749(03)80986-7 · ExternalCitation · doi-reference
Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial
10.1016/s2468-1253(23)00145-0 · ExternalCitation · doi-reference
Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial
10.1016/s2468-1253(26)00116-0 · ExternalCitation · doi-reference
10.1038/86365
10.1038/86365 · ExternalCitation · doi-reference
10.1038/ajg.2014.166
10.1038/ajg.2014.166 · ExternalCitation · doi-reference
Retrospective study of budesonide in children with eosinophilic gastroenteritis
10.1038/s41390-019-0444-2 · ExternalCitation · doi-reference
The oesophagus as an immune organ
10.1038/s41575-025-01086-4 · ExternalCitation · doi-reference
10.1053/j.gastro.2022.12.015
10.1053/j.gastro.2022.12.015 · ExternalCitation · doi-reference
Epidemiology, Natural History, and Treatment of Eosinophilic Gastrointestinal Diseases
10.1053/j.gastro.2025.09.030 · ExternalCitation · doi-reference
Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome
10.1056/nejmoa1812185 · ExternalCitation · doi-reference
10.1056/nejmoa2012047
10.1056/nejmoa2012047 · ExternalCitation · doi-reference
10.1097/00005792-197007000-00003
10.1097/00005792-197007000-00003 · ExternalCitation · doi-reference
10.1097/01.mpg.0000221903.61157.4e
10.1097/01.mpg.0000221903.61157.4e · ExternalCitation · doi-reference
Efficacy of Dietary Treatment for Inducing Disease Remission in Eosinophilic Gastroenteritis
10.1097/mpg.0000000000000766 · ExternalCitation · doi-reference
Prevalence of Eosinophilic Gastritis, Gastroenteritis, and Colitis: Estimates From a National Administrative Database
10.1097/mpg.0000000000000865 · ExternalCitation · doi-reference
High Patient Disease Burden in a Cross-sectional, Multicenter Contact Registry Study of Eosinophilic Gastrointestinal Diseases
10.1097/mpg.0000000000002817 · ExternalCitation · doi-reference
A Case Series on the Use of Dupilumab for Treatment of Refractory Eosinophilic Gastrointestinal Disorders
10.1097/mpg.0000000000003512 · ExternalCitation · doi-reference
Joint ESPGHAN/NASPGHAN Guidelines on Childhood Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis
10.1097/mpg.0000000000003877 · ExternalCitation · doi-reference
10.1097/pas.0000000000000481
10.1097/pas.0000000000000481 · ExternalCitation · doi-reference
A Systematic Review and Meta-Analysis on the Induction of Confirmed Eosinophilic Esophagitis as a Side Effect of Allergen Immunotherapy: An EAACI Task Force Report
10.1111/all.70183 · ExternalCitation · doi-reference
Letter: budesonide for functional dyspepsia with duodenal eosinophilia—randomised, double‐blind, placebo‐controlled parallel‐group trial
10.1111/apt.16396 · ExternalCitation · doi-reference
Non-oesophageal eosinophilic gastrointestinal diseases are undersuspected clinically and underdiagnosed pathologically
10.1111/apt.16971 · ExternalCitation · doi-reference
Clinical, histopathological features and efficacy of elimination diet and proton-pump inhibitor therapy in achieving histological remission in Asian children with eosinophilic gastritis
10.1111/jpc.15969 · ExternalCitation · doi-reference
Eosinophilic gastroenteritis developed after remission of cow’s milk allergy
10.1111/ped.14078 · ExternalCitation · doi-reference
Elemental diet therapy for eosinophilic gastroenteritis and dietary habits
10.1111/ped.14894 · ExternalCitation · doi-reference
Cysteinyl leukotrienes stimulate gut absorption of food allergens to promote anaphylaxis in mice
10.1126/science.adp0240 · ExternalCitation · doi-reference
Intestinal mast cell-derived leukotrienes mediate the anaphylactic response to ingested antigens
10.1126/science.adp0246 · ExternalCitation · doi-reference
Neuropsychiatric reactions with the use of montelukast
10.1136/bmj-2021-067554 · ExternalCitation · doi-reference
10.1136/gut.31.1.54
10.1136/gut.31.1.54 · ExternalCitation · doi-reference
Clinical Characteristics and Treatment Outcomes of Patients with Eosinophilic Esophagitis and Eosinophilic Gastroenteritis
10.1159/000511588 · ExternalCitation · doi-reference
10.1186/1476-7961-9-7
10.1186/1476-7961-9-7 · ExternalCitation · doi-reference
Successful use of montelukast in eosinophilic gastroenteritis: a case report and a literature review
10.1186/s12876-021-01854-x · ExternalCitation · doi-reference
Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report
10.1186/s13223-020-00423-3 · ExternalCitation · doi-reference
Transmural eosinophilic gastritis with gastric outlet obstruction: case report and review of the literature
10.1308/147870810x12659688851915 · ExternalCitation · doi-reference
Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter Consortium
10.14309/ajg.0000000000000228 · ExternalCitation · doi-reference
Prospective Endoscopic Activity Assessment for Eosinophilic Gastritis in a Multisite Cohort
10.14309/ajg.0000000000001625 · ExternalCitation · doi-reference
Eosinophilic Gastrointestinal Diseases Beyond Eosinophilic Esophagitis
10.14309/ajg.0000000000001658 · ExternalCitation · doi-reference
Collagenous Gastritis Masquerading as Eosinophilic Gastritis
10.14309/crj.0000000000000527 · ExternalCitation · doi-reference
Dupilumab Can Induce Remission of Eosinophilic Gastritis and Duodenitis: A Retrospective Case Series
10.14309/ctg.0000000000000646 · ExternalCitation · doi-reference
Determination of Optimal Eosinophil Thresholds for Diagnosis of Eosinophilic Gastritis and Duodenitis: A Pooled Analysis of 4 Prospective Studies
10.14309/ctg.0000000000000656 · ExternalCitation · doi-reference
Eosinophilic gastroenteritis as a cause of gastrointestinal tract bleeding and protein-losing enteropathy
10.14744/turkpediatriars.2018.48376 · ExternalCitation · doi-reference
10.17235/reed.2024.10660/2024
10.17235/reed.2024.10660/2024 · ExternalCitation · doi-reference
Eosinophilic gastroenteritis: diagnosis and clinical perspectives
10.2147/ceg.s173130 · ExternalCitation · doi-reference
Successful Treatment of Steroid-resistant Eosinophilic Gastrointestinal Disease with Mepolizumab
10.2169/internalmedicine.0801-22 · ExternalCitation · doi-reference
10.2169/internalmedicine.53.2111
10.2169/internalmedicine.53.2111 · ExternalCitation · doi-reference
Dupilumab Leads to Clinical Improvements including the Acquisition of Tolerance to Causative Foods in Non-Eosinophilic Esophagitis Eosinophilic Gastrointestinal Disorders
10.3390/biom13010112 · ExternalCitation · doi-reference
Eosinophilic gastroenteritis: Clinical experience with 15 patients
10.3748/wjg.v9.i12.2813 · ExternalCitation · doi-reference
Non-esophageal eosinophilic gastrointestinal diseases: a narrative review
10.51821/86.3.11869 · ExternalCitation · doi-reference
Combined eosinophilic gastroenteritis and ulcerative colitis successfully treated by vedolizumab: a case report
10.5217/ir.2024.00013 · ExternalCitation · doi-reference
Do General Pathologists Assess Gastric and Duodenal Eosinophilia?
10.5858/arpa.2022-0204-oa · ExternalCitation · doi-reference
